Full year 2024 net sales of $2.2 billion increased 0.8% year-over-year Full year 2024 income from operations of $430.0 million, resulting in an operating income margin of 19.3% Full year 2024 net income per diluted share of $7.60 Declared a $0.28 per share dividend Providing full year 2025 outlook PLEASANTON, Calif. , Feb. 10, 2025 /PRNewswire/ -- Simpson Manufacturing Co., Inc. (the "Company") (NYSE: SSD), an industry leader in engineered structural connectors and building solutions, today announced its financial results for the fourth quarter and full-year of 2024.

image for news SIMPSON MANUFACTURING CO., INC. ANNOUNCES 2024 FOURTH QUARTER AND FULL-YEAR FINANCIAL RESULTS

$4.0 million upfront with up to an additional $6.0 million of gross proceeds upon the exercise in full for cash of warrants TAREN POINT, Australia, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Fitell Corporation (Nasdaq: FTEL) (“Fitell” or the “Company”), an online retailer of gym and fitness equipment in Australia, today announced the closing of its previously announced registered direct offering of 796,813 ordinary shares and an additional investment right to purchase up to 1,195,220 ordinary shares in the form of warrants, at a purchase price of $5.02 per ordinary share and associated warrant. The warrants have an exercise price of …

image for news Fitell Corporation Announces Closing of Registered Direct Offering for up to $10.0 Million

COLUMBUS, Ohio--(BUSINESS WIRE)--T. Marzetti Company, a wholly owned subsidiary of Lancaster Colony Corporation (NASDAQ: LANC), is proud to announce that two of its recently-launched items have been named Product of the Year for 2025. New York Bakery™ Gluten Free Texas Toast was awarded the top gluten-free item. Texas Roadhouse™ Mini Rolls were named top bakery side dish. Product of the Year USA is the world's largest consumer-voted award for marketplace innovation, voted on by 40,000 consumers.

image for news T. Marzetti Wins 2025 Product of the Year Awards for New York Bakery Gluten Free Texas Toast and Texas Roadhouse Mini Rolls

PAPI: One Active Strategy, Two Income Sources — Positive

PAPI  SPY   ETF Trends — February 10, 2025

Income investors seeking the potential benefits of an actively managed strategy this year should consider the Parametric Equity Premium Income ETF (PAPI). The fund combines dividends income with a systematic options writing strategy to generate income for investors.

image for news PAPI: One Active Strategy, Two Income Sources

BRIXMOR PROPERTY GROUP REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS — Neutral

BRX   PRNewsWire — February 10, 2025

- Continues to Leverage Strong Tenant Demand - NEW YORK , Feb. 10, 2025 /PRNewswire/ -- Brixmor Property Group Inc. (NYSE: BRX) ("Brixmor" or the "Company") announced today its operating results for the three and twelve months ended December 31, 2024. For the three months ended December 31, 2024 and 2023, net income attributable to Brixmor Property Group, Inc. was $0.27 per diluted share and $0.24 per diluted share, respectively, and for the twelve months ended December 31, 2024 and 2023, net income attributable to Brixmor Property Group, Inc. was $1.11 per diluted share and $1.01 per diluted share, respectively.

image for news BRIXMOR PROPERTY GROUP REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS

Devon Energy: Shares Washed Out And Undervalued Heading Into Earnings — Neutral

DVN   Seeking Alpha — February 10, 2025

Devon Energy is rated a buy due to its compelling valuation, despite a 25% decline since August 2024 and recent oil price drops. Q3 2024 results showed strong production and revenue growth, beating estimates, with significant free cash flow and shareholder returns via buybacks and dividends. Risks include a weaker global economy, lower oil prices, and potential delays in new upstream assets impacting EPS growth forecasts.

image for news Devon Energy: Shares Washed Out And Undervalued Heading Into Earnings

Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024 Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024

image for news Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results and Updates 2025 Outlook

3M Rises 21.5% in Six Months: Should You Buy the Stock Now or Wait? — Negative

MMM   Zacks Investment Research — February 10, 2025

MMM is making strides in the transportation, roofing granules and electrical markets, which makes the stock worth a watch amid certain headwinds.

image for news 3M Rises 21.5% in Six Months: Should You Buy the Stock Now or Wait?

BLK Trades Below 52-Week High: Buy the Stock Before it Soars Again? — Positive

BLK   Zacks Investment Research — February 10, 2025

BlackRock shares are presently trading 8.5% below its 52-week high. Does this represent an opportunity to buy?

image for news BLK Trades Below 52-Week High: Buy the Stock Before it Soars Again?

3 Transportation Stocks Positioned to Surpass Q4 Earnings Estimates — Positive

ACDVF  GLNG  VLRS   Zacks Investment Research — February 10, 2025

Transportation stocks like ACDVF, VLRS and GLNG have the potential to deliver better-than-expected fourth-quarter results.

image for news 3 Transportation Stocks Positioned to Surpass Q4 Earnings Estimates

BlackBerry Soars 39% Year to Date: Is the Stock Still a Buy? — Positive

BB   Zacks Investment Research — February 10, 2025

BB's improving financial performance, strategic initiatives/collaborations and focus on IoT and Secure Communications units position it for long-term growth.

image for news BlackBerry Soars 39% Year to Date: Is the Stock Still a Buy?

Tower Semiconductor Ltd. (TSEM) Q4 2024 Earnings Call Transcript — Neutral

TSEM   Seeking Alpha — February 10, 2025

Tower Semiconductor Ltd. (NASDAQ:TSEM ) Q4 2024 Earnings Conference Call February 10, 2024 10:00 AM ET Company Participants Noit Levi - Senior Vice President of Investor Relations and Corporate Communications Russell Ellwanger - Chief Executive Officer Oren Shirazi - Chief Financial Officer, Senior Vice President of Finance Conference Call Participants Cody Acree - Benchmark Bastien Faucon-Morin - SIG Richard Shannon - Craig Hallum Lisa Thompson - ZACKS Investment Research Matthew Bryson - Wedbush Operator Good day and thank you for standing by.

image for news Tower Semiconductor Ltd. (TSEM) Q4 2024 Earnings Call Transcript

SAN FRANCISCO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- HashiCorp, Inc. (NASDAQ: HCP), The Infrastructure Cloud™ company, today announced it will release financial results for the fourth quarter of its 2025 fiscal year, which ended January 31, 2025, after the U.S. markets close Thursday, March 6, 2025.

image for news HashiCorp to announce fourth quarter fiscal year 2025 financial results on March 6, 2025

CHICAGO , Feb. 10, 2025 /PRNewswire/ -- Heidrick & Struggles International, Inc. (Nasdaq: HSII) ("Heidrick & Struggles", "Heidrick" or the "Company"), a premier provider of global leadership advisory and on-demand talent solutions, today announced it will host its quarterly conference call to discuss fourth quarter and full year 2024 financial results on Monday, March 3, 2025, at 5:00pm ET. The conference call and accompanying slides will be publicly available via live webcast on the investor relations section of the Heidrick & Struggles website at www.heidrick.com.

image for news Heidrick & Struggles to Release Fourth Quarter and Full Year 2024 Results

Prospect Capital Announces Financial Results for Fiscal December 2024 Quarter — Neutral

PSEC   GlobeNewsWire — February 10, 2025

NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”, “our”, or “we”) today announced financial results for our fiscal quarter ended December 31, 2024.

image for news Prospect Capital Announces Financial Results for Fiscal December 2024 Quarter

ConnectM Publishes 2024 Impact Scorecard — Neutral

CNTM   GlobeNewsWire — February 10, 2025

~Ends 2024 With Triple Digit Growth Across All Electrification Metrics~ MARLBOROUGH, Mass., Feb. 10, 2025 (GLOBE NEWSWIRE) -- ConnectM Technology Solutions, Inc. (NASDAQ:CNTM) ("ConnectM" or the "Company"), a technology company focused on the electrification economy, today published its impact scorecard for the fourth quarter of 2024.

image for news ConnectM Publishes 2024 Impact Scorecard

Sera Prognostics Announces Proposed Public Offering — Neutral

SERA   PRNewsWire — February 10, 2025

SALT LAKE CITY , Feb. 10, 2025 /PRNewswire/ -- Sera Prognostics, Inc., The Pregnancy Company® ("Sera" or the "Company") (Nasdaq: SERA), which focuses on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that it has commenced a proposed underwritten public offering of its Class A common stock and, in lieu of Class A common stock to certain investors, pre-funded warrants to purchase shares of its Class A common stock. In addition, Sera intends to grant the underwriters a 30-day option to purchase shares of Class A common stock in an amount …

image for news Sera Prognostics Announces Proposed Public Offering

Q4 Highlights: Revenue of $252.4 million Operating Margin of 21.6% Diluted earnings per share of $1.54 BEVERLY, Mass. , Feb. 10, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the fourth quarter and full year ended December 31, 2024.

image for news Axcelis Announces Financial Results for Fourth Quarter and Full Year 2024

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2, 2023 and October 30, 2024, both dates inclusive (the "Class Period"), of the important March 10, 2025 lead plaintiff deadline. So what: If you purchased Regeneron securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

image for news REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit

NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Novo Nordisk A/S (“Novo Nordisk” or “the Company”) (NYSE: NVO) and certain of its officers.

image for news NVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit